Natera Future Growth
Future criteria checks 4/6
Natera is forecast to grow earnings and revenue by 70.4% and 12.7% per annum respectively. EPS is expected to grow by 56% per annum. Return on equity is forecast to be 0.6% in 3 years.
Key information
70.4%
Earnings growth rate
56.0%
EPS growth rate
Biotechs earnings growth | 27.2% |
Revenue growth rate | 12.7% |
Future return on equity | 0.6% |
Analyst coverage | Good |
Last updated | 28 Jan 2025 |
Recent future growth updates
Recent updates
Natera: Poised For A Great Future But I'd Wait For A Pullback
Dec 31Is Natera (NASDAQ:NTRA) Weighed On By Its Debt Load?
Dec 30Subdued Growth No Barrier To Natera, Inc. (NASDAQ:NTRA) With Shares Advancing 25%
Nov 19Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158
Nov 15Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Oct 31Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 18Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?
Jul 05Natera: Overdue For A Breather
Jun 03Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119
May 12Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?
Mar 30Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
Mar 22Is Natera (NASDAQ:NTRA) A Risky Investment?
Mar 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 2,448 | 169 | 631 | 556 | 5 |
12/31/2026 | 2,127 | 30 | 199 | 312 | 17 |
12/31/2025 | 1,805 | -142 | 2 | 166 | 19 |
12/31/2024 | 1,632 | -196 | -102 | 95 | 19 |
9/30/2024 | 1,532 | -215 | -44 | 25 | N/A |
6/30/2024 | 1,361 | -292 | -118 | -56 | N/A |
3/31/2024 | 1,209 | -365 | -197 | -139 | N/A |
12/31/2023 | 1,083 | -435 | -286 | -247 | N/A |
9/30/2023 | 989 | -499 | -311 | -270 | N/A |
6/30/2023 | 931 | -512 | -387 | -343 | N/A |
3/31/2023 | 868 | -546 | -419 | -375 | N/A |
12/31/2022 | 820 | -548 | -479 | -432 | N/A |
9/30/2022 | 776 | -546 | -498 | -449 | N/A |
6/30/2022 | 723 | -576 | -492 | -438 | N/A |
3/31/2022 | 667 | -546 | -453 | -398 | N/A |
12/31/2021 | 625 | -472 | -385 | -335 | N/A |
9/30/2021 | 565 | -408 | -354 | -310 | N/A |
6/30/2021 | 505 | -315 | -280 | -252 | N/A |
3/31/2021 | 449 | -258 | -244 | -222 | N/A |
12/31/2020 | 391 | -230 | -202 | -183 | N/A |
9/30/2020 | 362 | -189 | -139 | -124 | N/A |
6/30/2020 | 342 | -153 | -117 | -104 | N/A |
3/31/2020 | 330 | -126 | -79 | -67 | N/A |
12/31/2019 | 302 | -125 | -68 | -63 | N/A |
9/30/2019 | 286 | -121 | -66 | -61 | N/A |
6/30/2019 | 273 | -128 | -76 | -72 | N/A |
3/31/2019 | 262 | -129 | -107 | -103 | N/A |
12/31/2018 | 258 | -128 | -74 | -71 | N/A |
9/30/2018 | 243 | -144 | -88 | -86 | N/A |
6/30/2018 | 233 | -142 | N/A | -94 | N/A |
3/31/2018 | 223 | -137 | N/A | -72 | N/A |
12/31/2017 | 210 | -138 | N/A | -98 | N/A |
9/30/2017 | 207 | -128 | N/A | -99 | N/A |
6/30/2017 | 205 | -126 | N/A | -92 | N/A |
3/31/2017 | 205 | -121 | N/A | -99 | N/A |
12/31/2016 | 213 | -100 | N/A | -74 | N/A |
9/30/2016 | 221 | -81 | N/A | -49 | N/A |
6/30/2016 | 212 | -72 | N/A | -42 | N/A |
3/31/2016 | 205 | -69 | N/A | -35 | N/A |
12/31/2015 | 190 | -70 | N/A | -38 | N/A |
9/30/2015 | 187 | -46 | N/A | -23 | N/A |
6/30/2015 | 189 | -28 | N/A | 0 | N/A |
3/31/2015 | 179 | -6 | N/A | 13 | N/A |
12/31/2014 | 159 | -5 | N/A | 10 | N/A |
9/30/2014 | 133 | -11 | N/A | -4 | N/A |
3/31/2014 | 78 | -29 | N/A | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NTRA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: NTRA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NTRA is expected to become profitable in the next 3 years.
Revenue vs Market: NTRA's revenue (12.7% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: NTRA's revenue (12.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NTRA's Return on Equity is forecast to be low in 3 years time (0.6%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 09:19 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Natera, Inc. is covered by 28 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Catherine Ramsey Schulte | Baird |
Luke Sergott | Barclays |
Raymond Myers | Benchmark Company |